A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2005
Has Results Drug: Almotriptan Malate Number of Pain Free Headaches at 2 and 24 Hours Post-Dose|Number of Headaches Achieving Pain Relief at 2 and 24 Hours Post-Dose|Number of Headaches With Photophobia|Number of Headaches With Phonophobia|Number of Headaches With Nausea|Number of Headaches With Vomiting All Phase 3 447 Industry Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment Cr002827|capss-368 December 2007
Epistemonikos ID: efeb8085fac66702e570b5ff65f8b82abe398e25
First added on: May 04, 2024